How Healthcare Leaders Should Evaluate Digital Health Companies

Échec de l'ajout au panier.

Veuillez réessayer plus tard

Échec de l'ajout à la liste d'envies.

Veuillez réessayer plus tard

Échec de la suppression de la liste d’envies.

Veuillez réessayer plus tard

Échec du suivi du balado

Ne plus suivre le balado a échoué

How Healthcare Leaders Should Evaluate Digital Health Companies

Écouter gratuitement

Voir les détails du balado

À propos de cet audio

Healthcare leaders are flooded with digital health vendors promising AI, efficiency, and better outcomes. Many never make it past a pilot.

In this episode of Health/Tech Edge, I talk with Sally Ann Frank, Global Lead for Health and Life Sciences at Microsoft for Startups and author of The Startup Protocol and The Unicorn Protocol, about how healthcare executives should evaluate digital health companies.

We cover why pilots fail, how to spot founder blind spots, what signals real execution and staying power, and how leaders can choose partners that will actually scale.

If you’re a healthcare executive buying or partnering with digital health companies, this one’s for you.

Pas encore de commentaire